Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Clinical trial NCT00182689 · COMPLETED

Trial details

NCT number: NCT00182689
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer Recurrent Small Cell Lung Cancer

Start date: 2005-07-01
Primary completion: 2008-10-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.